Dialysis world news


Hydration During PCI Reduces Contrast Nephropathy - Renal and Urology News
April 21, 2015 Hydration During PCI Reduces Contrast Nephropathy - Renal and Urology News
Contrast-Induced Nephropathy is significantly associated with mortality and need for dialysis; hydration is also a predictor of CIN.

(HealthDay News) -- Hydration during primary percutaneous coronary intervention (PPCI) is associated with a reduction in the risk of contrast-induced nephropathy (CIN), according to a study published in The American Journal of Cardiology.

In an effort to examine the role of hydration in prevention of CIN, Alfonso Jurado-Román, M.D., from University Hospital 12 de Octubre in Madrid, and colleagues conducted a prospective trial involving 408 consecutive patients with ST-segment elevation myocardial infarction undergoing PPCI. Participants were randomized to receive hydration with isotonic saline from the beginning of the procedure until 24 hours after it (NS+) or not (NS?).

The researchers identified CIN in 14% of patients: 21% in the NS? group and 11% in the NS+ group (P = 0.016). There were significant correlations for CIN with death (15.2 versus 2.8%; P < 0.0001) and the need for dialysis (13.4 versus 0%; P < 0.0001). The only predictors of CIN in multivariate analysis were hydration (odds ratio, 0.29; P = 0.003) and hemoglobin before the procedure (odds ratio, 0.69; P < 0.0001).

"Patients with CIN had increased mortality and need for dialysis," the authors write. "Given the higher incidence of CIN in emergent procedures, and its morbidity and mortality, preventive hydration should be mandatory in them unless contraindicated."

Source

  1. Jurado-Román, A, et al. The American Journal of Cardiology; doi: http://dx.doi.org/10.1016/j.amjcard.2015.02.004.

...

 
BRIEF-Senzime acquires company developing products for micro dialysis - Reuters

BRIEF-Senzime acquires company developing products for micro dialysis
Reuters
Says that it has acquired MD Biomedical AB, a company that developed and patented products for micro dialysis. * Acquisition is financed by newly issued shares in Senzime. * Says purchase price amounts to 200,000 newly issued Senzime shares (current ...

...

 
Lack of mechanism to control infection during dialysis - Business Standard
Business Standard
Citing lack of mechanism to control infection during dialysis to patients in the Stanley Medical College Hospital here, Madras High Court has said it expected that adequate interim compensation would be paid to affected persons before the next hearing

...

 
DNA abnormalities found in children with chronic kidney disease - Medical Xpress
Depiction of genomic imbalances detected in patients with chronic kidney disease. The human chromosomes are shown (numbered). The colored bars represent the pathogenic genomic deletions (red) and duplications (blue) detected in a patient. In total, the study identified 21 different genetic lesions in 31 patients, indicating that most patients had a unique genomic pathology. The size of each bar is proportional to the size of the genomic lesion. Credit: Dr. Ali Gharavi

A significant proportion of children with chronic kidney disease (CKD) have unsuspected chromosomal imbalances, including DNA anomalies that have been linked to neurocognitive disorders, according to a new Columbia University Medical Center (CUMC) study. The findings suggest that routine genetic screening of children with CKD could lead to earlier and more precise diagnoses, as well as to more personalized monitoring, prevention, and treatment. Details of the study were published today in the online issue of the Journal of Clinical investigation.

"With conventional clinical findings, we often cannot determine the exact cause of CKD in ," said study leader Ali G. Gharavi, MD, professor of medicine and chief of the Division of Nephrology at CUMC. "However, our study shows that using a readily available genetic screening tool called chromosomal microarray analysis, it's possible in many cases to reach a more precise diagnosis and uncover information that can help define a patient's risk for other disorders, such as autism or diabetes."

About 13 percent of Americans are affected by CKD. The disease is particularly serious in children, often leading to complications like high blood pressure, heart disease, neurodevelopmental problems, and behavioral deficits. Roughly half of all cases of CKD in children are caused by birth defects, such as an underdeveloped or missing kidney. CKD can also result from hereditary diseases, infection, toxic exposures, and autoimmune disorders. In many patients, the cause cannot be determined.

Dr. Gharavi, together with lead author Miguel Verbistky, PhD, associate research scientist, and their colleagues, hypothesized that copy number variations (CNVs)—gain or loss of bits of DNA—might provide insights into the cause of CKD in children. The team performed chromosomal microarray analyses of 419 children enrolled in the Chronic Kidney Disease in Children (CKiD) Prospective Cohort Study to determine the prevalence of disease-causing CNVs among various categories of pediatric CKD. The data were compared with genomic data on 21,575 healthy pediatric and adult controls.

The researchers found significant CNVs in 31, or 7.4 percent, of the 419 children with CKD (roughly ten-fold the percentage seen in the controls). The most frequent CNVs were deletions in the HNF1B gene. Loss of HNF1B function is associated with renal cysts and diabetes syndrome, which increases one's susceptibility to kidney malformations, diabetes, and cognitive disorders, among other conditions. Many of the other CNVs that were uncovered were associated with developmental delays, intellectual disabilities, and seizure disorders.

Of the 31 children with significant CNVs, 28 had genetic diagnoses that differed from the clinical diagnosis or that added information that would have altered the care of the patient, according to the study.

"Because kidney problems can be detected early by blood tests, or even by prenatal imaging studies, this offers the opportunity for screening and detecting genomic imbalances before other complications, such as developmental delay, become clinically apparent," said Dr. Verbistky.

"Our findings should change clinical practice," said Dr. Gharavi. "Routine of kids with CKD would not only improve diagnosis but also help identify those at risk for complications like diabetes and subclinical seizures, which benefit from early detection and treatment."

The findings also shed light on why children with CKD tend to perform less well in school than their peers. "The prevailing hypothesis," said Dr. Gharavi, "is that their poor academic performance is due simply to impaired kidney function and the burden of having a chronic illness. But our data suggest that these kids may be underperforming because of an underlying genetic lesion that affects both kidney and neurologic function. If so, it's important that we identify these potential problems and intervene as early as possible."

More information: "Chromosomal Microarrays for the Diagnosis of Pediatric Chronic Kidney Disease," Journal of Clinical investigation, 2015.

Journal reference: Journal of Clinical Investigation

Provided by Columbia University Medical Center

17 shares

...

 
Ribbon cutting for Fresenius Dialysis - Emporia Gazette

Posted: Monday, April 20, 2015 2:30 pm | Updated: 2:30 pm, Mon Apr 20, 2015.

The Emporia Area Chamber and Visitors Bureau will hold a ribbon cutting at 11:30 a.m. Thursday for Fresenius Dialysis, 1602 W. 15th Ave. The community is invited to attend.

...

 
<< Start < Prev 151 152 153 154 155 156 157 158 159 160 Next > End >>

Page 155 of 2630
Share |
Copyright © 2024 Global Dialysis. All Rights Reserved.